INBS PE Ratio & Valuation, Is INBS Overvalued

Historical Valuation

Intelligent Bio Solutions Inc (INBS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of -1.44. The fair price of Intelligent Bio Solutions Inc (INBS) is between 3.82 to 8.61 according to relative valuation method. Compared to the current price of 3.22 USD , Intelligent Bio Solutions Inc By Undervalued By 15.76%.

Relative Value

Fair Zone

3.82-8.61

Current Price：3.22

15.76%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Intelligent Bio Solutions Inc (INBS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Intelligent Bio Solutions Inc (INBS) has a current Price-to-Book (P/B) ratio of 1.98. Compared to its 3-year average P/B ratio of 1.46, the current P/B ratio is approximately 35.90% higher. Relative to its 5-year average P/B ratio of 1.58, the current P/B ratio is about 25.47% higher. Intelligent Bio Solutions Inc (INBS) has a Forward Free Cash Flow (FCF) yield of approximately -139.97%. Compared to its 3-year average FCF yield of -166.93%, the current FCF yield is approximately -16.15% lower. Relative to its 5-year average FCF yield of -119.74%, the current FCF yield is about 16.90% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for INBS competitors is 0.47, providing a benchmark for relative valuation. Intelligent Bio Solutions Inc Corp (INBS.O) exhibits a P/S ratio of 0.28, which is -39.94% above the industry average. Given its robust revenue growth of 47.62%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of INBS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of INBS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is INBS currently overvalued or undervalued?

Intelligent Bio Solutions Inc (INBS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of -1.44. The fair price of Intelligent Bio Solutions Inc (INBS) is between 3.82 to 8.61 according to relative valuation method. Compared to the current price of 3.22 USD, Intelligent Bio Solutions Inc is Undervalued By 15.76%.

What is Intelligent Bio Solutions Inc (INBS) fair value?

INBS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Intelligent Bio Solutions Inc (INBS) is between 3.82 to 8.61 according to relative valuation method.

How does INBS's valuation metrics compare to the industry average?

The average P/S ratio for INBS's competitors is 0.47, providing a benchmark for relative valuation. Intelligent Bio Solutions Inc Corp (INBS) exhibits a P/S ratio of 0.28, which is -39.94% above the industry average. Given its robust revenue growth of 47.62%, this premium appears sustainable.

What is the current P/B ratio for Intelligent Bio Solutions Inc (INBS) as of Mar 31 2026?

As of Mar 31 2026, Intelligent Bio Solutions Inc (INBS) has a P/B ratio of 1.98. This indicates that the market values INBS at 1.98 times its book value.

What is the current FCF Yield for Intelligent Bio Solutions Inc (INBS) as of Mar 31 2026?

As of Mar 31 2026, Intelligent Bio Solutions Inc (INBS) has a FCF Yield of -139.97%. This means that for every dollar of Intelligent Bio Solutions Inc's market capitalization, the company generates -139.97 cents in free cash flow.

What is the current Forward P/E ratio for Intelligent Bio Solutions Inc (INBS) as of Mar 31 2026?

As of Mar 31 2026, Intelligent Bio Solutions Inc (INBS) has a Forward P/E ratio of 2.25. This means the market is willing to pay $2.25 for every dollar of Intelligent Bio Solutions Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Intelligent Bio Solutions Inc (INBS) as of Mar 31 2026?

As of Mar 31 2026, Intelligent Bio Solutions Inc (INBS) has a Forward P/S ratio of 0.28. This means the market is valuing INBS at $0.28 for every dollar of expected revenue over the next 12 months.

INBS Valuation